2 July 2018 - Deborah Wilkes
Archived
A consortium led by private-equity firm CVC Capital Partners is acquiring a majority stake in Italian pharmaceutical company Recordati for EUR3.03 billion (USD3.50 billion).
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.